COMMUNIQUÉS West-GlobeNewswire

iCAD Announces Pricing of Public Offering of Common Stock
13/06/2019
NASHUA, N.H., June 13, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (“iCAD”) (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, announced today the pricing of its [...]
Cambium Networks Corporation Announces Launch of Initial Public Offering
13/06/2019
ROLLING MEADOWS, Ill., June 13, 2019 (GLOBE NEWSWIRE) -- Cambium Networks Corporation (“Cambium”), a provider of wireless broadband networking infrastructure solutions, today announced that it has launched the roadshow [...]
Arcturus Therapeutics Announces Redomiciliation to the United States as a Delaware Corporation
13/06/2019
SAN DIEGO, June 13, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) (the “Company”), a leading messenger RNA medicines company focused on the discovery, development and commercialization of [...]
Tonix Pharmaceuticals Announces Issuance of Patent in China for the Composition and Formulation of TNX-102 SL
13/06/2019
Patent Expected to Provide Intellectual Property Protection until 2034 in China NEW YORK, June 13, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage [...]
BrainsWay to Present at the 2019 Raymond James Life Sciences and MedTech Conference
13/06/2019
JERUSALEM and HACKENSACK, N.J., June 13, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE:BWAY) (BrainsWay” or the “Company”), a commercial stage medical device company focused on the development and sale of [...]
HEXO MED, an affiliate of HEXO Corp, secures medical cannabis license in Europe
13/06/2019
ATHENS, Greece, June 13, 2019 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO ; NYSE-A: HEXO ) is pleased to announce that its affiliate, HEXO MED S.A. (“HEXO MED”) has received a medical cannabis [...]
HEXO MED, une filiale de HEXO Corp, obtient une licence pour la production de cannabis médical en Europe
13/06/2019
ATHÈNES, Grèce, 13 juin 2019 (GLOBE NEWSWIRE) -- HEXO Corp (« HEXO » ou la « Société ») (TSX : HEXO ; NYSE-A : HEXO) a le plaisir d'annoncer que sa filiale, HEXO MED S.A. (« HEXO MED ») a obtenu une licence pour ses [...]
Orasure Technologies to Present at Raymond James 2019 Life Sciences and MedTech Conference
13/06/2019
BETHLEHEM, Pa., June 13, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced that Mr. Roberto Cuca, Chief [...]
PHOTOS: Aleafia Health Completes Planting of Canada’s First Legal Outdoor Cannabis Crop
13/06/2019
• 13,000 Cannabis Plants now Growing at Company’s Outdoor Grow Facility • Harvest of First Outdoor Crop Planned for Q3 2019 • Planting of Crop Completed Less Than One Week Following Health Canada Approval TORONTO, June [...]
Zealand Pharma implements a new long-term incentive program and grants new warrants under the employee warrant program
13/06/2019
Company announcement – No. 20 / 2019 Zealand Pharma implements a new long-term incentive program and grants new warrants under the employee warrant program Copenhagen, June 13, 2019 – Zealand Pharma A/S (“Zealand”) ( [...]
Crown Bioscience annonce quatre nouveaux modèles précliniques de la NASH en développement
13/06/2019
- Réaffirme son engagement pour la découverte de médicaments contre la NASH - SAN DIEGO, 13 juin 2019 (GLOBE NEWSWIRE) -- Crown Bioscience, société mondiale de services de découverte et de développement de médicaments [...]
Oncology Venture increases its ownership in dovitinib
13/06/2019
Press release Hoersholm, Denmark, June 13, 2019 – Oncology Venture A/S (Nasdaq First North Stockholm: OV.ST) has acquired an additional 8% ownership in the dovitinib project from Sass & Larsen Aps. Following the [...]
ESPERITE (ESP) resumes negotiations regarding proposed sale of stem cell banking business to PBKM
13/06/2019
Amsterdam, The Netherlands – 13 June 2019 Esperite N.V. (Euronext: ESP, “Esperite”) announces today that it has resumed negotiations with Polski Bank Komórek Macierzystych S.A. (WSE: PBKM, “PBKM”) regarding the proposed [...]
Bone Therapeutics’ allogeneic cell therapy product, ALLOB, meets primary endpoints in Phase IIa study in patients undergoing a lumbar spinal fusion procedure
13/06/2019
Regulated Information – Inside Information Treatment with ALLOB resulted in significant clinical and radiological improvements Treatment with ALLOB was well-tolerated, consistent with previous reported results At 12 [...]
Bone Therapeutics SA : ALLOB, le produit de thérapie cellulaire allogénique de Bone Therapeutics, valide les principaux critères d’évaluation de l’étude de phase IIa chez des patients ayant subi une procédure de fusion vertébrale
13/06/2019
Information règlementaire – Information confidentielle Le traitement par ALLOB induit des améliorations significatives tant au niveau clinique que radiologique Bon profil de tolérance d’ALLOB, cohérent avec les [...]
Efficacy and safety data with Idorsia's dual orexin receptor antagonist presented at SLEEP 2019 in San Antonio
13/06/2019
Allschwil, Switzerland – June 13, 2019 Idorsia Ltd (SIX: IDIA) today announced that efficacy and safety data from two Phase 2 studies of ACT‑541468, Idorsia's dual orexin receptor antagonist, for the treatment of adult [...]
HEXO Corp reports third quarter 2019 financial results
13/06/2019
Key highlights of third quarter of 2019 fiscal year HEXO remains on-track ramping up to $400 million net revenue in fiscal 2020 and to double net revenue in Q4 fiscal 2019 Entered a syndicated credit facility with CIBC [...]
HEXO Corp annonce ses résultats financiers pour le troisième trimestre de 2019
13/06/2019
Faits marquants du troisième trimestre de l’exercice 2019 HEXO poursuit ses efforts visant à atteindre des revenus nets de 400 millions de dollars à l’exercice 2020 et à multiplier par deux le montant de ses revenus [...]
MediciNova to Present at the JMP Securities Life Sciences Conference
13/06/2019
LA JOLLA, Calif., June 12, 2019 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]

Pages